191 related articles for article (PubMed ID: 20145716)
21. Type-specific human papillomavirus prevalence in cervical intraepithelial neoplasia and cancer in Iran.
Heydari N; Oskouee MA; Vaezi T; Shoja Z; Esmaeili HA; Hamkar R; Shahmahmoodi S; Jalilvand S
J Med Virol; 2018 Jan; 90(1):172-176. PubMed ID: 28786495
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of human papillomavirus types 16, 18, and 45 in women with cervical intraepithelial changes: associations with colposcopic and histological findings.
Jarienė K; Vaitkienė D; Bartusevičius A; Tvarijonavičienė E; Minkauskienė M; Nadišauskienė R; Kruminis V; Kliučinskas M
Medicina (Kaunas); 2012; 48(1):22-30. PubMed ID: 22481371
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of human papillomavirus infection among women with and without normal cervical histology in Shandong Province, China.
Yuan X; Yang Y; Gu D; Liu H; Yang H; Wang M
Arch Gynecol Obstet; 2011 Jun; 283(6):1385-9. PubMed ID: 20628750
[TBL] [Abstract][Full Text] [Related]
24. Pre-vaccination epidemiology of human papillomavirus infections in Japanese women with abnormal cytology.
Yamasaki K; Miura K; Shimada T; Ikemoto R; Miura S; Murakami M; Sameshima T; Fujishita A; Kotera K; Kinoshita A; Yoshiura K; Masuzaki H
J Obstet Gynaecol Res; 2011 Nov; 37(11):1666-70. PubMed ID: 21793993
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.
Otero-Motta AP; Ordóñez JL; González-Celador R; Rivas B; Macías Mdel C; Bullón A; Abad Mdel M
APMIS; 2011 Mar; 119(3):204-15. PubMed ID: 21284738
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa.
Denny L; Adewole I; Anorlu R; Dreyer G; Moodley M; Smith T; Snyman L; Wiredu E; Molijn A; Quint W; Ramakrishnan G; Schmidt J
Int J Cancer; 2014 Mar; 134(6):1389-98. PubMed ID: 23929250
[TBL] [Abstract][Full Text] [Related]
27. Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence.
Kjær SK; Frederiksen K; Munk C; Iftner T
J Natl Cancer Inst; 2010 Oct; 102(19):1478-88. PubMed ID: 20841605
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of genital human papillomavirus infection and genotypes among women from Fujian province, PR China.
Wu D; Cai L; Huang M; Zheng Y; Yu J
Eur J Obstet Gynecol Reprod Biol; 2010 Jul; 151(1):86-90. PubMed ID: 20226583
[TBL] [Abstract][Full Text] [Related]
29. Human Papillomavirus Genotyping to Predict the Risk of Cervical Precancerous Lesions or Cancer in Women with Minor Abnormal Cytology in China.
Lin CQ; Cui JF; Zhang X; Pan QJ; Chen W; Qiao YL
Acta Cytol; 2015; 59(5):405-11. PubMed ID: 26565687
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis.
Ogembo RK; Gona PN; Seymour AJ; Park HS; Bain PA; Maranda L; Ogembo JG
PLoS One; 2015; 10(4):e0122488. PubMed ID: 25875167
[TBL] [Abstract][Full Text] [Related]
31. Distribution of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasive cervical cancer in Canada.
Coutlée F; Ratnam S; Ramanakumar AV; Insinga RR; Bentley J; Escott N; Ghatage P; Koushik A; Ferenczy A; Franco EL
J Med Virol; 2011 Jun; 83(6):1034-41. PubMed ID: 21503917
[TBL] [Abstract][Full Text] [Related]
32. [The role of human papillomavirus in cyto-histological practice: distribution and prevalenceof hig-risk strains (16, 18, 31, 33, and 35) in intraepithelial lesions and neoplasia of the uterine cervix].
Voglino G; Poso F; Privitera S; Parisio F; Ghiringhello B; Gordini G; Chiara G; Massobrio M; Fessia L
Pathologica; 2000 Dec; 92(6):516-23. PubMed ID: 11234302
[TBL] [Abstract][Full Text] [Related]
33. Stratified risk of high-grade cervical disease using onclarity HPV extended genotyping in women, ≥25 years of age, with NILM cytology.
Stoler MH; Wright TC; Parvu V; Yanson K; Cooper CK; Andrews J
Gynecol Oncol; 2019 Apr; 153(1):26-33. PubMed ID: 30638767
[TBL] [Abstract][Full Text] [Related]
34. Introduction of liquid-based cytology and human papillomavirus testing in cervical cancer screening in Luxembourg.
Latsuzbaia A; Hebette G; Fischer M; Arbyn M; Weyers S; Vielh P; Schmitt F; Mossong J
Diagn Cytopathol; 2017 May; 45(5):384-390. PubMed ID: 28247516
[TBL] [Abstract][Full Text] [Related]
35. Detection and Type-Distribution of Human Papillomavirus in Vulva and Vaginal Abnormal Cytology Lesions and Cancer Tissues from Thai Women.
Ngamkham J; Boonmark K; Phansri T
Asian Pac J Cancer Prev; 2016; 17(3):1129-34. PubMed ID: 27039737
[TBL] [Abstract][Full Text] [Related]
36. High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy.
Piana A; Sotgiu G; Cocuzza C; Musumeci R; Marras V; Pischedda S; Deidda S; Muresu E; Castiglia P
PLoS One; 2013; 8(5):e63395. PubMed ID: 23717420
[TBL] [Abstract][Full Text] [Related]
37. Analysis of human papillomavirus type-16 variants in Italian women with cervical intraepithelial neoplasia and cervical cancer.
Tornesello ML; Duraturo ML; Salatiello I; Buonaguro L; Losito S; Botti G; Stellato G; Greggi S; Piccoli R; Pilotti S; Stefanon B; De Palo G; Franceschi S; Buonaguro FM
J Med Virol; 2004 Sep; 74(1):117-26. PubMed ID: 15258977
[TBL] [Abstract][Full Text] [Related]
38. Human papillomavirus type distribution in cervical intraepithelial neoplasia grade 2/3 and cervical cancer in Portugal: a CLEOPATRE II Study.
Pista A; de Oliveira CF; Lopes C; Cunha MJ;
Int J Gynecol Cancer; 2013 Mar; 23(3):500-6. PubMed ID: 23392401
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age.
Xi LF; Touré P; Critchlow CW; Hawes SE; Dembele B; Sow PS; Kiviat NB
Int J Cancer; 2003 Mar; 103(6):803-9. PubMed ID: 12516102
[TBL] [Abstract][Full Text] [Related]
40. Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation.
Mesher D; Cuschieri K; Hibbitts S; Jamison J; Sargent A; Pollock KG; Powell N; Wilson R; McCall F; Fiander A; Soldan K
J Clin Pathol; 2015 Feb; 68(2):135-40. PubMed ID: 25410654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
